{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:43:35Z","timestamp":1779252215047,"version":"3.51.4"},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:00:00Z","timestamp":1538611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Microbicide Trials Network"},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068633"],"award-info":[{"award-number":["UM1AI068633"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI068615"],"award-info":[{"award-number":["UM1AI068615"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UM1AI106707"],"award-info":[{"award-number":["UM1AI106707"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,3,19]]},"DOI":"10.1093\/cid\/ciy653","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T15:12:34Z","timestamp":1533654754000},"page":"1136-1143","source":"Crossref","is-referenced-by-count":26,"title":["Phase 1 Safety and Pharmacokinetics Study of MK-2048\/Vicriviroc (MK-4176)\/MK-2048A Intravaginal Rings"],"prefix":"10.1093","volume":"68","author":[{"given":"Craig J","family":"Hoesley","sequence":"first","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice A","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Pittsburgh, Pennsylvania"},{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L","family":"Anderson","sequence":"additional","affiliation":[{"name":"Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene S","family":"Dezzutti","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Pittsburgh, Pennsylvania"},{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julie","family":"Strizki","sequence":"additional","affiliation":[{"name":"Merck & Co. Inc., Kenilworth, New Jersey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Sprinkle","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faye","family":"Heard","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Bauermeister","sequence":"additional","affiliation":[{"name":"University of Pennsylvania, Philadelphia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Hall","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cindy","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Magee-Womens Research Institute, Pittsburgh, Pennsylvania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Berthiaume","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Statistical Center for HIV\/AIDS Research and Prevention, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashley","family":"Mayo","sequence":"additional","affiliation":[{"name":"FHI360, Durham, North Carolina"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Gundacker","sequence":"additional","affiliation":[{"name":"Fred Hutchinson Cancer Research Center, Statistical Center for HIV\/AIDS Research and Prevention, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Richardson-Harman","sequence":"additional","affiliation":[{"name":"Alpha StatConsult LLC, Damascus"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanna","family":"Piper","sequence":"additional","affiliation":[{"name":"National Institutes of Health, Division of AIDS, Bethesda, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Microbicide Trials Network 027 Study Team","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,10,4]]},"reference":[{"key":"key\n\t\t\t\t2019031909372391600_CIT0001","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0015-0282(16)37333-2","article-title":"Contraceptive effect of varying dosages of progestogen in silastic vaginal rings","volume":"21","author":"Mishell","year":"1970","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0002","first-page":"62","article-title":"State of the art in intravaginal ring technology for topical prophylaxis of HIV infection","volume":"14","author":"Kiser","year":"2012","journal-title":"AIDS Rev"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0003","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1056\/NEJMoa1602046","article-title":"Safety and efficacy of a dapivirine vaginal ring for HIV prevention in women","volume":"375","author":"Nel","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0004","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa1506110","article-title":"Use of a vaginal ring containing dapivirine for HIV-1 prevention in women","volume":"375","author":"Baeten","year":"2016","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0005","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1202614","article-title":"Preexposure prophylaxis for HIV infection among African women","volume":"367","author":"Van Damme","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0006","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/QAD.0000000000001452","article-title":"Acceptability and use of a dapivirine vaginal ring in a phase III trial","volume":"31","author":"Montgomery","year":"2017","journal-title":"AIDS"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0007","unstructured":"Brown E , Palanee-PhilipsT, MarzinkeM, et al Residual dapivirine ring levels indicate higher adherence to vaginal ring is associated with HIV-1 protection. In: AIDS 2016; Durban, South Africa."},{"key":"key\n\t\t\t\t2019031909372391600_CIT0008","volume-title":"Investigator\u2019s Brochure: Vicriviroc (SCH 417690) Maleate","author":"Merck & Co. Inc","year":"2010"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0009","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/QAI.0b013e3181c9caac","article-title":"Pharmacokinetic\/pharmacodynamic modeling of the antiretroviral activity of the CCR5 antagonist Vicriviroc in treatment experienced HIV-infected subjects (ACTG protocol 5211)","volume":"53","author":"Crawford","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0010","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1128\/JVI.06421-11","article-title":"HIV-1 clinical isolates resistant to CCR5 antagonists exhibit delayed entry kinetics that are corrected in the presence of drug","volume":"86","author":"Putcharoen","year":"2012","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0011","volume-title":"Investigator\u2019s Brochure: MK-2048","author":"Merck & Co. Inc","year":"2005"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0012","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/AAC.01733-09","article-title":"Cross-resistance profile determination of two second-generation HIV-1 integrase inhibitors using a panel of recombinant viruses derived from raltegravir-treated clinical isolates","volume":"55","author":"Van Wesenbeeck","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0013","volume-title":"Investigator\u2019s Brochure. MK-2048A (Combination intravaginal ring containing vicriviroc and MK-2048)","author":"Merck & Co., Inc","year":"2014"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0014","year":"2004"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0015"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0016","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/QAI.0b013e318291f331","article-title":"HIV-1 infection of female genital tract tissue for use in prevention studies","volume":"63","author":"Dezzutti","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0017","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/QAI.0000000000000996","article-title":"Cervicovaginal and rectal fluid as a surrogate marker of antiretroviral tissue concentration: implications for clinical trial design","volume":"72","author":"Cottrell","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0018","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1089\/aid.2013.0032","article-title":"Short communication: expression of transporters and metabolizing enzymes in the female lower genital tract: implications for microbicide research","volume":"29","author":"Zhou","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0019","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1124\/dmd.114.060194","article-title":"CYP3A5 genotype impacts maraviroc concentrations in healthy volunteers","volume":"42","author":"Lu","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0020","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/QAI.0000000000000702","article-title":"Phase 1 safety, pharmacokinetics, and pharmacodynamics of dapivirine and maraviroc vaginal rings: a double-blind randomized trial","volume":"70","author":"Chen","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0021","doi-asserted-by":"crossref","first-page":"e4174","DOI":"10.1097\/MD.0000000000004174","article-title":"Pharmacodynamic correlations using fresh and cryopreserved tissue following use of vaginal rings containing dapivirine and\/or maraviroc in a randomized, placebo controlled trial","volume":"95","author":"Dezzutti","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0022","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1007\/s10461-016-1299-8","article-title":"Adherence and acceptability of a multidrug vaginal ring for HIV prevention in a phase I study in the United States","volume":"20","author":"van der Straten","year":"2016","journal-title":"AIDS Behav"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0023","doi-asserted-by":"crossref","first-page":"e0147743","DOI":"10.1371\/journal.pone.0147743","article-title":"Safety, acceptability and adherence of dapivirine vaginal ring in a microbicide clinical trial conducted in multiple countries in Sub-Saharan Africa","volume":"11","author":"Nel","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t2019031909372391600_CIT0024","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","article-title":"Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial","volume":"111","author":"Creinin","year":"2008","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/7\/1136\/28114940\/ciy653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,21]],"date-time":"2019-10-21T20:12:11Z","timestamp":1571688731000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/7\/1136\/5115615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,4]]},"references-count":24,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,10,4]]},"published-print":{"date-parts":[[2019,3,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy653","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4,1]]},"published":{"date-parts":[[2018,10,4]]}}}